Johnson & Johnson
Search results
Janssen is a global biopharmaceutical company that develops and delivers innovative medicines to treat and prevent complex diseases. Learn more about Janssen's vision, values, products, careers, and social responsibility.
- Careers
My colleagues are smart and value each other’s knowledge....
- Contact Us
Contact Janssen in the US or globally for corporate...
- Janssen United States
We prioritize support for activities within Janssen’s areas...
- Oncology
The Janssen Oncology team is working with intentional focus...
- About Us
At Janssen, we’re creating a future where disease is a thing...
- Our Company
Our Company - Pharmaceutical Companies of Johnson & Johnson...
- Our Focus
Our Focus - Pharmaceutical Companies of Johnson & Johnson |...
- Our Science
Our Science - Pharmaceutical Companies of Johnson & Johnson...
- Announcement
The Janssen Pharmaceutical Companies of Johnson & Johnson is...
- Grants & Giving
Our responsibilities, as set forth in Our Credo, guide...
- Careers
Johnson & Johnson Innovative Medicine (formerly Janssen Pharmaceuticals) is a pharmaceutical company headquartered in Beerse, Belgium, and wholly-owned by Johnson & Johnson. It was founded in 1953 by Paul Janssen.
Janssen offers various programs and services to help U.S. patients access and afford its medicines. Learn about Janssen CarePath, Johnson & Johnson Patient Assistance Foundation, and Medicine Assistance Tool.
People also ask
When did Janssen Pharmaceutica become a company?
When did Janssen Pharmaceuticals start?
Where can I find a copy of a Janssen Pharmaceutical filing?
Who are Janssen and Ortho-McNeil Pharmaceuticals?
Jun 11, 2024 · We prioritize support for activities within Janssen’s areas of scientific interest that contribute to improved knowledge, practice and performance for healthcare providers and improved health outcomes for patients.
Feb 27, 2021 · Learn how the single-dose vaccine works, how it has been studied, how it would be transported and more. The company announces that it has been granted Emergency Use Authorization by the U.S. FDA.
NEW BRUNSWICK, N.J., February 27, 2021 – Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 ...
Mar 3, 2021 · Learn how Johnson & Johnson developed and produced its Janssen COVID-19 Vaccine in less than a year, with the help of global partners and existing technologies. See the steps from cell growth to vial filling and distribution.
